BLADDER CANCER

This study looked at how well the drug Adstiladrin works for bladder cancer when used in regular doctor visits, not just in strict research settings. Researchers planned to follow 202 patients in the US and Israel to see if the drug could make tumors disappear. The study was stop…

This study tested a new pill, BI 907828, in adults with advanced cancers of the bile duct, pancreas, lung, or bladder that have a specific genetic change (MDM2 amplification). The goal was to see if the drug could shrink tumors. The study was stopped early, but the results may st…

This early-phase study tested a new medicine called PF-07921585, given alone or with another drug (sasanlimab), in adults with advanced solid tumors like lung, bladder, kidney, skin, head and neck, or colorectal cancer. The goal was to check safety and how the body handles the dr…

This study tested a drug called tovorafenib in people aged 12 and older whose cancers had returned or worsened and had certain gene changes (MAPK pathway). The goal was to see if the drug could shrink tumors. The study was stopped early, so results are limited.

This study tested a new drug called OC-001, given alone or with an immunotherapy drug (Avelumab), in people with advanced cancers that had spread. The goal was to check safety and how the drug moves through the body. The study was stopped early and involved 73 participants with v…

This study tested whether adding the immunotherapy drug avelumab to standard radiation therapy could help treat muscle-invasive bladder cancer in patients who cannot receive the chemotherapy drug cisplatin. The trial enrolled 14 participants and aimed to see if the combination co…

This study tested whether adding trilaciclib to standard chemotherapy and maintenance therapy could help people with advanced bladder cancer. The trial was stopped early, so results are limited. It involved 92 adults with untreated, advanced or metastatic urothelial carcinoma.

This early-stage study tested a new drug called SO-C101, either alone or with another drug (pembrolizumab), in 115 people with advanced solid tumors like lung, kidney, or skin cancer. The main goal was to check safety and find the right dose. The study was stopped early, so resul…

This study looked at whether a urine test (DEK ELISA) can accurately detect bladder cancer in people with symptoms like blood in urine or painful urination. Researchers measured a protein called DEK in urine samples from over 1,100 participants and compared the results to standar…

This study tested a special technique that combines organizing traumatic memories with slow, deep breathing to reduce PTSD symptoms in people with advanced cancer and their partners. The goal was to see if this approach could lower stress, inflammation, and possibly improve survi…

This study looked at whether genetic changes found in urine can match those found in tumor tissue for people with high-risk bladder cancer that hasn't spread into the muscle. The goal was to see if a urine test could help doctors choose the right immunotherapy for each patient. T…